Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
International Chemical Investors Group Acquires Roche’s API Site in U.S.
5:46 AM MDT | August 9, 2011 | Deepti Ramesh
The International Chemical Investors Group (ICIG; Frankfurt) says it has signed an agreement with Roche (Basel, Switzerland) to acquire Roche Colorado Corp. (Boulder, CO), which includes Roche’s pharmaceutical production facility at Boulder. ICIG will acquire the Roche affiliate company in Boulder with its technical development and small molecule manufacturing capabilities. ICIG will operate the Boulder site and it will be renamed Corden Pharma Colorado. Corden Pharma is the pharmaceutical arm of ICIG investments. Corden Pharma Colorado will supply Roche...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee